Actinic keratosis treated with an immune response modifier: A case report of six patients

Clinical and Experimental Dermatology, Supplement

Volumn 28, Issue 1, 2003, Pages 39-41

  Bianchi, L ^a   Campione, E ^a   Marulli, G C ^a   Costanzo, A ^a   Chimenti, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BURNING SENSATION; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; KERATINOCYTE; LONG TERM EXPOSURE; MALE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION; ULTRAVIOLET RADIATION; CASE REPORT; KERATOSIS; MIDDLE AGED; PHOTOSENSITIVITY DISORDER; TOPICAL DRUG ADMINISTRATION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; DRUG EFFICACY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; TREATMENT OUTCOME;

EID: 1542435161     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.13.x     Document Type: Article

References (13)

1. Moy RL. Clinical presentation of actinic keratosis and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8-10.
2. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001; 144: 1050-3.
3. Marks R, McCarthy WH. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; I: 296-7.
4. Yantsos VA, Conrad N, Zabawsky E, Cockerell JJ. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratosis. Semin Cutan Med Surg 1999: 18: 3-14.
5. Cockerell JJ. Histopathology of incipient intraepidermal squamous cell carcinoma (actinic keratosis). J Am Acad Dermatol 2000; 42: 11-7.
6. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000; 42: S25-8.
7. Flowers F. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. Int J Dermatol 2002; 41: 12-5.
8. Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunothera 1999; 21: 1-14.
9. Stockfleth E, Ulrich C, Salasche SJ, Christophers E. A randomized, double-blind, vehicle-controlled study to assess imiquimod 5% cream for the treatment of actinic keratosis. Arch Dermatol 2002; 138: 1498-502.
10. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open label trial. J Am Acad Dermatol 2002; 47: 571-7.
11. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. Part I: methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-7.
12. Marks R. Epidemiology of non-melanoma skin cancer and solar keratoses in Australia: a tale of self-immolation in Elysian fields. Aus J Dermatol 1997; 38: 26-9.
13. Dinehart SM, Chu DZ, Manners AW, Pollack SV. Immunosuppression in patients with metastatic squamous cell carcinoma from the skin. J Dermatol Surg Oncol 1990; 16: 271-4.